Sei Investments Co. boosted its position in shares of Hill-Rom Holdings Inc (NYSE:HRC) by 20.5% during the second quarter, Holdings Channel reports. The institutional investor owned 142,070 shares of the medical technology company’s stock after buying an additional 24,130 shares during the period. Sei Investments Co.’s holdings in Hill-Rom Holdings were worth $11,309,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Independent Portfolio Consultants Inc. increased its stake in Hill-Rom Holdings by 171.5% in the second quarter. Independent Portfolio Consultants Inc. now owns 1,344 shares of the medical technology company’s stock worth $107,000 after buying an additional 849 shares in the last quarter. Meadow Creek Investment Management LLC increased its stake in Hill-Rom Holdings by 3.9% in the first quarter. Meadow Creek Investment Management LLC now owns 1,696 shares of the medical technology company’s stock worth $120,000 after buying an additional 64 shares in the last quarter. Neuburgh Advisers LLC increased its stake in Hill-Rom Holdings by 3.9% in the first quarter. Neuburgh Advisers LLC now owns 2,332 shares of the medical technology company’s stock worth $165,000 after buying an additional 88 shares in the last quarter. Atria Investments LLC purchased a new stake in Hill-Rom Holdings during the second quarter worth about $224,000. Finally, Tyers Asset Management LLC increased its stake in Hill-Rom Holdings by 3.9% in the first quarter. Tyers Asset Management LLC now owns 2,968 shares of the medical technology company’s stock worth $210,000 after buying an additional 112 shares in the last quarter. Institutional investors and hedge funds own 84.00% of the company’s stock.

Hill-Rom Holdings Inc (NYSE:HRC) opened at 74.28 on Thursday. Hill-Rom Holdings Inc has a 52 week low of $50.50 and a 52 week high of $84.65. The company’s 50 day moving average price is $79.86 and its 200-day moving average price is $72.65. The company has a market capitalization of $4.89 billion, a P/E ratio of 43.29 and a beta of 1.22.

Hill-Rom Holdings (NYSE:HRC) last posted its earnings results on Friday, July 28th. The medical technology company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $689.10 million for the quarter, compared to analyst estimates of $695.50 million. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. Hill-Rom Holdings’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the company earned $0.81 earnings per share. Equities research analysts expect that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, September 29th. Investors of record on Friday, September 15th will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.97%. The ex-dividend date is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio (DPR) is 41.62%.

ILLEGAL ACTIVITY NOTICE: This article was reported by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark laws. The original version of this article can be read at https://www.watchlistnews.com/sei-investments-co-purchases-24130-shares-of-hill-rom-holdings-inc-nysehrc/1468691.html.

A number of equities research analysts have issued reports on the company. BidaskClub downgraded Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Stifel Nicolaus restated a “buy” rating and set a $84.00 price target on shares of Hill-Rom Holdings in a research note on Sunday, July 30th. Zacks Investment Research downgraded Hill-Rom Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Cantor Fitzgerald set a $86.00 price target on Hill-Rom Holdings and gave the company a “hold” rating in a research note on Friday, July 28th. Finally, Needham & Company LLC cut their price objective on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating for the company in a research note on Friday, July 28th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $88.17.

In other Hill-Rom Holdings news, SVP Paul Sherwood Johnson sold 2,078 shares of the firm’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total value of $150,239.40. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Andreas G. Frank sold 10,660 shares of the firm’s stock in a transaction that occurred on Tuesday, June 6th. The shares were sold at an average price of $78.62, for a total value of $838,089.20. Following the completion of the sale, the senior vice president now directly owns 28,988 shares in the company, valued at $2,279,036.56. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

Hill-Rom Holdings Company Profile

Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.

Want to see what other hedge funds are holding HRC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hill-Rom Holdings Inc (NYSE:HRC).

Institutional Ownership by Quarter for Hill-Rom Holdings (NYSE:HRC)

Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.